{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:42:36Z","timestamp":1790707356541,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.yebeh.2020.107462","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T20:27:10Z","timestamp":1600720030000},"page":"107462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6671-3597","authenticated-orcid":false,"given":"Katrina T.","family":"Roberto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-1833","authenticated-orcid":false,"given":"Adrian I.","family":"Espiritu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Laurence L.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine C.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107462_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0010","first-page":"290","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"Van Sonderen","year":"2017","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.yebeh.2020.107462_bb0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0020","first-page":"1","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","author":"Van Sonderen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.yebeh.2020.107462_bb0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107462_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107462_bb0035","first-page":"1","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","author":"Finke","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2020.107462_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/epi.13436","article-title":"Subclinical temporal EEG seizure pattern in LGI1-antibody-mediated encephalitis","volume":"57","author":"Steriade","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107462_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clinph.2017.10.014","article-title":"Clinical neurophysiology frontal infraslow activity marks the motor spasms of anti-LGI1 encephalitis","volume":"129","author":"Wennberg","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0050","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/WNL.0b013e3182152808","article-title":"Tonic seizures: a diagnostic clue of anti-lgi1 encephalitis?","author":"Andrade","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107462_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.yebeh.2020.107462_bb0060","first-page":"8","article-title":"Limbic encephalitis with LGI1 antibodies in a 14-year-old boy","author":"Schimmel","year":"2017","journal-title":"Off J Eur Paediatr Neurol Soc Case"},{"key":"10.1016\/j.yebeh.2020.107462_bb0065","first-page":"1","article-title":"LGI1 antibody encephalitis and psychosis","author":"Wang","year":"2018","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107462_bb0070","author":"Konuskan","year":"2017","journal-title":"SC. Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00906","article-title":"Pediatric autoimmune encephalitis: case series from two Chinese tertiary pediatric neurology centers","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0080","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(14)60684-X","article-title":"Case report pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies","volume":"383","author":"Sen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2020.107462_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.041","article-title":"Epilepsy & behavior clinical characterization of autoimmune LGI1 antibody limbic encephalitis","volume":"56","author":"Gao","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107462_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0972-2327.120480","article-title":"Facio-brachio-crural dystonic episodes and drop attacks due to leucine rich glioma inactivated 1 encephalitis in two elderly Indian women","volume":"16","author":"Maramattom","year":"2013","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1251-4","article-title":"Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review","volume":"19","author":"Li","year":"2019","journal-title":"BMC Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0100","first-page":"000","article-title":"Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series","volume":"0","author":"Yang","year":"2019","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2020.107462_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0110","first-page":"1","article-title":"Brain sciences psychiatric manifestation of anti-LGI1 encephalitis","volume":"10375","author":"Endres","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.yebeh.2020.107462_bb0115","first-page":"10","article-title":"Pilomotor seizures in a patient with LGI1 encephalitis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0120","doi-asserted-by":"crossref","unstructured":"Yuan X, Man X, Zhang J, Sun J, Liang J, Ma H. Anti-leucine-rich glioma inactivated-1 encephalitis associated with essential thrombocythemia Intern Med. 2020:271\u20135. doi:https:\/\/doi.org\/10.2169\/internalmedicine.2963-19.","DOI":"10.2169\/internalmedicine.2963-19"},{"key":"10.1016\/j.yebeh.2020.107462_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2018.08.019","article-title":"Epilepsy & behavior clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis","volume":"88","author":"Li","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107462_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3174\/ng.1800035","article-title":"Anti-LGI1 encephalitis: a case report of a recently described disease entity","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Neurographics"},{"key":"10.1016\/j.yebeh.2020.107462_bb0135","first-page":"1","article-title":"Case report. A patient with limbic encephalitis associated with presenting with slowly progressive cognitive impairment and fluctuating striatal lesions","author":"Sato","year":"2018","journal-title":"Intern Med Adv Publ"},{"key":"10.1016\/j.yebeh.2020.107462_bb0140","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.12659\/AJCR.916945","article-title":"Syncope and twitching at the emergency","author":"Scutelnic","year":"2019","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.yebeh.2020.107462_bb0145","first-page":"1","article-title":"Rapidly progressive global cerebral atrophy in the setting of anti-LGI1 encephalitis","author":"Yelam","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.yebeh.2020.107462_bb0150","first-page":"000","article-title":"Three cases of antibody-LGI1 limbic encephalitis and review of literature","volume":"0","author":"Wang","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2020.107462_bb0155","first-page":"1","article-title":"A 9-year neuropsychological report of a patient with LGI1-associated limbic encephalitis","volume":"00","author":"Zangrandi","year":"2019","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0160","first-page":"1","article-title":"Autoimmune encephalitis associated with voltage-gated potassium a national cohort study","volume":"0","author":"Celicanin","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yebeh.2017.08.011","article-title":"Epilepsy & behavior seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis","volume":"77","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107462_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2171-6625.1000137","article-title":"A case of limbic encephalitis: antibody LGI1 associated encephalitis","volume":"7","author":"Bhardwaj","year":"2016","journal-title":"J Neurol Neurosci"},{"key":"10.1016\/j.yebeh.2020.107462_bb0175","first-page":"1","article-title":"Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yebeh.2020.107462_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2016.00068","article-title":"Leucine-rich glioma inactivated-1 and voltage-gated potassium channel autoimmune encephalitis associated with ischemic stroke: a case report","volume":"7","author":"Mcginley","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0185","first-page":"1","article-title":"Anti-LGI1 limbic encephalitis \u2014 case report","volume":"3","author":"S\u00e1","year":"2016","journal-title":"Open Access Libr J"},{"key":"10.1016\/j.yebeh.2020.107462_bb0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/s1980-5764-2016dn1004016","article-title":"The importance of recognizing faciobrachial dystonic seizures in rapidly progressive dementias","volume":"10","author":"Simabukuro","year":"2016","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0195","first-page":"31","article-title":"Late diagnosis of limbi encephalitis associated with LGI1 antibodies leading to relapses","volume":"21","author":"Franca","year":"2015","journal-title":"J Epilepsy Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0200","first-page":"7041","article-title":"Case report LGI1-antibody encephalitis with subsequent rapid progression of diffuse cerebral atrophy: a case report","volume":"9","author":"Guo","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.yebeh.2020.107462_bb0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5144\/0256-4947.2015.76","article-title":"Case report","volume":"35","author":"Messelmani","year":"2015","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.yebeh.2020.107462_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000441944","article-title":"The treatment and follow-up of anti-LGI1 limbic encephalitis","volume":"75","author":"Yu","year":"2016","journal-title":"Eur Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/etm.2015.2866","article-title":"Anti-leucine-rich glioma-inactivated 1 limbic encephalitis: a case report and literature review","volume":"11","author":"Liu","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.yebeh.2020.107462_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000051","article-title":"Leucine-rich glioma-inactivated protein 1 antibody encephalitis","volume":"1","author":"Mayasi","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.yebeh.2020.107462_bb0225","first-page":"95","article-title":"A rare case of limbic encephalitis with anti leucine-rich glioma inactivated-1 (LGI1) antibodies","volume":"35","author":"Shen","year":"2014","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.yebeh.2020.107462_bb0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5607\/en.2013.22.4.337","article-title":"Anti-LGI1 limbic encephalitis presented with atypical manifestations","volume":"22","author":"Lee","year":"2013","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0235","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jocn.2011.12.025","article-title":"Treatment of limbic encephalitis with anti-glioma-inactivated 1 (LGI1) antibodies","volume":"19","author":"Krastinova","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2020.107462_bb0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107462_bb0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107462_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000682","article-title":"Pediatric autoimmune encephalitis: recognition and diagnosis","volume":"7","author":"de Bruijn","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.yebeh.2020.107462_bb0255","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.22467","article-title":"Faciobrachial dystonic attacks: seizures or movement disorder","volume":"70","author":"Striano","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0260","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede LGI1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0265","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2020.107462_bb0270","first-page":"1","article-title":"The electroencephalography of encephalopathy in patients with endocrine and metabolic disorders Roland","volume":"30","author":"Faigle","year":"2014","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107462_bb0275","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00335-007-9024-6","article-title":"Defining the expression pattern of the LGI1 gene in BAC transgenic mice","volume":"18","author":"Head","year":"2007","journal-title":"Mamm Genome"},{"key":"10.1016\/j.yebeh.2020.107462_bb0280","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/epi4.12226","article-title":"Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1","volume":"3","author":"Feyissa","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2020.107462_bb0285","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1172\/JCI125178","article-title":"Autoimmune seizures and epilepsy","volume":"129","author":"Geis","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yebeh.2020.107462_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020306429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:36:30Z","timestamp":1761503790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020306429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":58,"alternative-id":["S1525505020306429"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107462","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107462"}}